Anorexia nervosa in female adolescents: Endocrine and bone mineral density disturbances

European Journal of Endocrinology

Volumn 147, Issue 3, 2002, Pages 275-286

  Munoz M T ^a   Argente, J ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUCOSE; GONADOTROPIN; HYDROCORTISONE; LEPTIN; MELANOCORTIN; NEUROPEPTIDE Y; NEUROTRANSMITTER; PHOSPHATE; SOMATOMEDIN C; THYROID HORMONE;

ADIPOSE TISSUE; ADOLESCENT; AMENORRHEA; ANOREXIA NERVOSA; BONE DENSITY; BONE DISEASE; BONE MINERAL; CALORIC INTAKE; CHILDHOOD DISEASE; CONTROLLED STUDY; DELAYED PUBERTY; DIET RESTRICTION; DISEASE ASSOCIATION; ELECTROLYTE DISTURBANCE; ENDOCRINE DISEASE; FEMALE; FOOD CONTROL; FRACTURE; GONADOTROPIN RELEASE; HORMONE DEFICIENCY; HUMAN; HYPERCORTISOLISM; HYPOGLYCEMIA; HYPOPHOSPHATEMIA; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; HYPOTHYROIDISM; MENTAL DISEASE; METABOLIC DISORDER; OLIGOMENORRHEA; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; WEIGHT REDUCTION;

EID: 0036739455     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470275     Document Type: Review

References (122)

1. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 1994.
2. Hsu LK. Epidemiology of the eating disorders. Psychiatric Clinics of North America 1996 19 681-760.
3. Pérez-Gaspar M, Gual P, de Irala-Estevez J, Martínez-Gonzalez MA, Lahortiga F & Cervera S. Prevalencia de los trastornos de la conducta alimentaria en los adolescentes navarros. Medicina Clinica 2000 114 481-486.
4. Schwartz MW, Seeley RJ, Campfeld LA, Burn P & Baskin DG. Identification of targets of leptin action in rat hypothalamus. Journal of Clinical Investigation 1996 98 1101-1106.
5. Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Ogushi K & Borowie M. Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity. Diabetes, Obesity and Metabolism 2000 2 99-103.
6. Schwartz MW, Woods SC, Porte D, Seeley RJ & Baskin DG. Cerebral nervous system control of food intake. Nature 2000 404 661-671.
7. Kaye WH, Berrettini NH, Gwirstman HE, Gold PW, Jimerson DC & Ebert MH. Contribution of CNS neuropeptide (NPY, CRH and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa. Psychopharmacology Bulletin 1989 25 433-438.
8. Rogol AD. Leptin and puberty. Journal of Clinical Endocrinology and Metabolism 1998 83 1089-1090.
9. Argente J, Barrios V, Chowen JA, Sinha MK & Considine RV. Leptin plasma levels in healthy Spanish children and adolescents with obesity and adolescents with anorexia nervosa and bulimia nervosa. Journal of Pediatrics 1997 131 833-838.
10. Hinney A, Bornscheuer A, Depenbusch M, Mierke B, Tolle A, Middeke K et al. No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity: identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region. Molecular Psychiatry 1988 3 539-543.
11. Billington CJ, Briggs JE, Grace M & Levine AS. Effect of intracerebroventricular injection of neuropeptide Y on energy metabolism. American Journal of Physiology 1991 260 321-327.
12. Gerald C, Walker AW, Criscione L, Gustafson EL, Batzl-Hartman C, Smith KE et al. A receptor subtype involved in neuropeptide-Y induced food intake. Nature 1996 382 168-171.
13. Rosenkranz K, Hinney A, Ziegler A, Hermann H, Fichter M, Mayer H et al. Screening for mutations in the neuropetide YY5 receptor gene in cohorts belonging to different weight extremes. International Journal of Obesity-Related Metabolism Disorders 1988 22 157-163.
14. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeansenaud F & Jeansenaud B. Glucocorticoids as contraregulatory hormones of leptin: towards an understanding of leptin resistance. Diabetes 1997 46 717-719.
15. Sakurai T, Amemiya A, Ishii M, Matsuzaki T, Chemelli RM, Tamaka H et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998 92 573-585.
16. Fan W, Boston B, Kesterson R, Hruby V & Cone R. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997 385 165-168.
17. Hinney A, Schmidt A, Nottebom K, Heibitt O, Becker I, Ziegler A et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. Journal of Clinical Endocrinology and Metabolism 1999 84 1483-1486.
18. Halford JC & Blundell JE. Separate systems for serotonin and leptin in appetite control. Annals of Medicine 2000 32 222-232.
19. Hinney A, Remschmidt H & Hebebrand J. Candidate gene polymorphisms in eating disorders. European Journal of Pharmacology 2000 410 147-159.
20. Collier DA, Arranz MJ, Li T, Mupita D, Brown N & Treasure J. Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet 1997 350 412.
21. Enoch MA, Kaye WH, Rotondo A, Greenberg BD, Murphy DL & Goldman D. 5-HT2A promoter polymorphism-1438 G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet 1998 351 1785-1786.
22. Ziegler A, Hebebrand J, Gorg T, Rosenkranz K, Fichter M, Herpertz-Dahlamam B et al. Further lack of association between the 5-HT2A gene promoter polymorphism and susceptibility to eating disorders and a meta-analysis pertaining to anorexia nervosa. Molecular Psychiatry 1999 4 410-412.
23. Nacmias B, Ricca V, Tedde A, Mezzani B, Rotella CM & Sorbi S. 5-HT2A receptor gene polymorphism in anorexia nervosa and bulimia nervosa. Neuroscience Letters 1999 277 134-136.
24. Aubert R, Betonlla D, Herbeth B, Siest G & Fumaron F. 5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people. International Journal of Obesity-Related Metabolism Disorders 2000 24 920-924.
25. Spigset O, Andersen T, Hagg S & Mjondal T. Enhanced platelet serotonin 5-HT2A receptor binding in anorexia nervosa and bulimia nervosa. European Neuropsychopharmacology 1999 9 469-473.
26. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA & Burn P. Leptin increase hypothalamic pro-opiomelanocortin mRNA expresion in the rostral arcuate nucleus. Diabetes 1997 46 2119-2123.
27. Schenry CC, Clifton DK & Steiner RA. Proopiomelanocortin neurons and direct targets for leptin in the hypothalamus. Endocrinology 1997 138 4489-4492.
28. Gold PW, Gwritsman H, Augerinos PC, Nieman LK, Galluci WT, Kaye W et al. Abnormal hypothalamic pituitary-adrenal function in anorexia nervosa. Pathophysiology mechanisms in underweight and weight-corrected patients. New England Journal of Medicine 1986 314 1339-1342.
29. Foppiani L, Sessarego P, Valenti S, Falivene MR, Cuttica CM & Giusti Disem M. Lack of effect of desmopressin on ACTH and cortisol responses to ovine corticotropin-releasing hormone in anorexia nervosa. European Journal of Endocrinology 1996 26 879-883.
30. Estour B, Pugeat M, Lang F, Lejeune H, Brountin F, Pellet J et al. Rapid esacape of cortisol from suppression in response to i.v. dexamethasone in anorexia nervosa. Clinical Endocrinology 1990 33 45-52.
31. Boyar RM, Hellman LD, Roffwarg H, Katz J, Zumoff B, O'Connor J et al. Cortisol secretion and metabolism in anorexia nervosa. New England Journal of Medicine 1977 296 190-194.
32. Cavagnini F, Invitti C, Passamonti M & Polli EE. Response of ACTH and cortisol to corticotropin-releasing hormone in anorexia nervosa. New England Journal of Medicine 1986 314 184-185.
33. Putignano P, Dubini A, Toja P, Invitti C, Bonfati S, Redaelli G et al. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. European Journal of Endocrinology 2001 145 165-171.
34. Shibasaki T, Imaki T, Hotta M, Ling N & Demura H. Psychological stress increases arousal through brain corticotropin-releasing hormone without significant increase in adrenocorticotropin and catecholamine secretion. Brain Research 1993 618 71-75.
35. Couzinet B, Young J, Brailly S, LeBuc Y, Chanson P & Schaison G. Functional hypothalamic amenorrhea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clinical Endocrinology 1999 50 229-235.
36. Muñoz MT, Morandé G & Argente J. Anomalías en el patrón de secreción de gonadotropinas en las pacientes adolescentes afectadas de anorexia nerviosa. Endocrinología 1997 44 248-252.
37. Baranowska B. Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa? Psychoneuroendocrinology 1990 15 371-379.
38. Terasawa EI & Fernandez DL. Neurobiological mechanism of the onset of puberty in primates. Endocrine Reviews 2001 22 111-151.
39. Thissen JP & Ketelslegers JM. Endocrine response to undernutrition from the experimental model to human physiology. In Clinical Issues in Growth Disorders: Evaluation, Diagnosis and Therapy pp 131-150. Eds A Prader & R Rappaport. London: Freund Publishing House Ltd, 1994.
40. Stoving RK, Hangaard J & Hagen C. Update on endocrine disturbances in anorexia nervosa. Journal of Pediatric Endocrinology and Metabolism 2001 14 459-480.
41. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996 382 250-252.
42. Hileman SM, Pierroz DD & Flier JS. Leptin, nutrition, and reproduction: timing is everything. Journal of Clinical Endocrinology and Metabolism 2000 85 804-807.
43. Warren MP, Voussonghian F, Geer EB, Hyle EP, Adberg CL & Ramos RH. Functional hypothalamic amenorrhea: hypoleptinemia and disordered eating. Journal of Clinical Endocrinology and Metabolism 1999 84 873-877.
44. Kopp W, Blum WF, von Prittwitz S, Ziegler A, Lubbert H, Emons G et al. Low leptin levels predict amenorrhea in underweight and eating disordered females. Molecular Psychiatry 1997 2 335-340.
45. Monteleone P, Di Lieto A, Tortorella A, Longobardi N & Maj M. Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge-eating disorder: relationship to body weight, eating patterns, psychopathology and endocrine changes. Psychiatry Research 2000 15 121-129.
46. Balligand JL, Brichard SM, Brichard V, Desager JP & Lambert M. Hypoleptinemia in patients with anorexia nervosa: loss of circadian rhythm and unresponsiveness to short-term refeeding. European Journal of Endocrinology 1998 138 415-420.
47. Nakai Y, Hamagaki S, Kato S, Seino Y, Takagi R & Kurinoto F. Leptin in women with eating disorders. Metabolism 1999 48 217-220.
48. Mortola JF, Laughlin GA & Yen SSC. Melatonin rhythms in women with anorexia nervosa and bulimia nervosa. Journal of Clinical Endocrinology and Metabolism 1993 77 1540-1544.
49. García-Patterson A, Muñoz MT, Puig-Domingo M, Argente J & Webb SM. Urine 6 sulphatoxymelatonin excretion during anorexia nervosa treatment. In Panel Update: From Molecular Biology to Clinical Medicine, pp 255-262. Eds S Webb, M Puig-Domingo, M Moller & P Pevet. New York: PJD Electronic Publications Editorial, 1997.
50. Okatani Y & Sagara Y. Enhanced nocturnal melatonin secretion in women with functional secondary amenorrhea: relationship to opioid system and endogenous estrogen levels. Hormone Research 1995 43 194-199.
51. García MT, Muñoz MT, Barrios V, Martínez G, Hawkins F & Argente J. Total body fat is a better parameter for determining nutritional status in adolescents with anorexia nervosa than leptin levels or body mass index. Pediatric Research 2001 49 132.
52. Iketani T, Kirike N, Nagata T & Yamagami S. Altered body fat distribution after recovery of weight in patients with anorexia nervosa. International Journal of Eating Disorders 1999 26 275-282.
53. Golden N, Jacobson MS, Schebendach J, Solanto MV, Hertz SM & Shenker R. Resumption of menses in anorexia nervosa. Archives of Pediatric and Adolescence Medicine 1997 151 16-21.
54. Genazzani AD, Petraglia F, Gastaldi M, Gamba O, Corazza F, D'Ambrogio G et al. Growth hormone (GH)-releasing hormone-induced GH response in hypothalamic amenorrhea: evidence of altered central neuromodulation. Fertility and Sterility 1996 65 935-938.
55. Nussbaum MP, Blethen SL, Chasalow FI, Jacobson MS, Shenker IR & Feldman J. Blunted growth hormone responses to clonidine in adolescent girls with early anorexia nervosa. Evidence for an early hypothalamic defect. Journal of Adolescent Health Care 1990 11 145-148.
56. Scacchi M, Invitti C, Pincelli AI, Pandolfi C, Dubini A & Cvagnini F. Lack of growth hormone response to acute administration of dexamethasone in anorexia nervosa. European Journal of Endocrinology 1995 132 152-158.
57. Giusti M, Foppiani L, Ponzani P, Cuttica CM, Falivene MR & Valenti S. Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa. Journal of Endocrinological Investigation 1997 20 257-263.
58. Scacchi M, Pincelli AI, Caumo A, Tomasi P, Delitala G, Baldi G et al. Spontaneous nocturnal growth hormone secretion in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 1997 82 3225-3229.
59. Argente J, Caballo N, Barrios V, Muñoz MT, Pozo J, Chowen JA et al. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation. Journal of Clinical Endocrinology and Metabolism 1997 82 2084-2092.
60. Støving RK, Veldhuis JD, Flyvbjerg A, Vinten J, Hangaard J, Koldkjaer OG et al. Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. Journal of Clinical Endocrinology and Metabolism 1999 84 2056-2063.
61. Gianotti L, Pincelli AI, Scachi M, Rolla M, Bellitu D, Arvat E et al. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2000 85 2805-2809.
62. Cummings E, Purnell JQ, Frayo SR, Schmidova K, Wisse BE & Weigle DS. A pre-prandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001 50 1714-1719.
63. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. European Journal of Endocrinology 2001 145 R5-R9.
64. Plata-Salaman CR. Leptin, anorexia nervosa, and anorexia of acute and chronic disease. Nutrition 1999 15 943-945.
65. Hochberg Z, Hertz P, Colin V, Ish-Shalom S, Yeshurun D, Youdim MBH & Amit T. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 1992 41 106-112.
66. Counts DR, Gwirtsman H, Carlsson LMS, Lesem M & Cutler GB Jr. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. Journal of Clinical Endocrinology and Metabolism 1992 75 762-767.
67. Golden NH, Kreitzer P, Jacobson MS, Chasalow FI, Schebendach J, Freedman SM et al. Disturbances in growth hormone secretion and action in adolescents with anorexia nervosa. Journal of Pediatrics 1994 125 655-660.
68. Argente J, Muñoz MT, Pozo J, Barrios V, Buño M, Chowen JA et al. Growth hormone resistance in anorexia nervosa as a model of malnutrition. Journal of Endocrinological Investigation 1998 21 24-28.
69. Zamboni G, Dufillot D, Antoniazzi F, Valentini R, Gendrel D & Tato L. Growth hormone binding proteins and insulin-like growth factor-binding proteins in protein-energy malnutrition, before and after nutritional rehabilitation. Pediatric Research 1996 39 410-414.
70. Maes M, Underwood LE & Ketelslegers JM. Plasma somatomedin-C in fasted and refed rats: close relationship with changes in liver somatogenic, but not lactogenic, binding sites. Journal of Endocrinology 1983 97 243-252.
71. Massa G, Igout A, Rombauts L, Frankenne F & Vanderschueren Lodeweyckx M. Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor I in non-pregnant and pregnant women. Clinical Endocrinology 1993 39 569-575.
72. Roelen CAM, Koppeschaar HPF, De Vries WR, Snel YEM, Doerga ME, Zelissen PMJ et al. Visceral adipose tissue is associated with circulating high affinity growth hormone binding protein. Journal of Clinical Endocrinology and Metabolism 1997 82 760-764.
73. Ketelslegers JM, Maiter D, Maes M, Underwood LE & Thissen JP. Nutritional regulation of insulin-like growth factor I. Metabolism 1995 44 (Suppl) 50-57.
74. Hernández M, Argente J, Navarro A, Caballo N, Barrios V, Hervás F et al. Growth in malnutrition related to gastrointestinal diseases: coeliac disease. Hormone Research 1992 38 79-84.
75. Støving RK, Flyvbjerg A, Frystyc J, Fisker S, Hangaard J, Hansen-nord M et al. Low serum levels of free and total insulin-like growth factor I (IFG-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis. Journal of Clinical Endocrinology and Metabolism 1999 84 1346-1350.
76. Straus DS, Hayden JM & Marten NW. Molecular mechanisms for nutritional regulation of genes for IGF-I, IGF-binding proteins and other plasma proteins. In The Insulin-Like Growth Factors and their Regulatory Proteins, pp 33-41. Eds RC Baxter, PD Gluckman & RG Rosenfeld. Amsterdam: Elsevier Science BV, 1994.
77. Rajaram S, Baylink DJ & Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocrine Reviews 1997 18 801-831.
78. Bang P, Nygren J, Carlsson SC, Thorell A & Ljungquist O. Post-operative induction of insulin-like growth factor binding protein-3 proteolytic activity: relation to insulin and insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 1998 83 2509-2515.
79. Argente J, Barrios V, Chowen JA, Muñoz MT, Pozo J & Hernández M. Insulin-like growth factor binding protein (IGFBP) 4 and 5 levels in patients with anorexia nervosa. Hormone Research 1997 48 (Suppl) 42 (A251).
80. Kiyohara K, Tamai H, Takaichi Y, Nakagawa T & Kumagai LF. Decreased thyroidal triiodothyronine secretion in patients with anorexia nervosa: influence of weight recovery. American Journal of Clinical Nutrition 1989 50 767-772.
81. Muñoz MT & Argente J. Anorexia nerviosa y bulimia nerviosa. In Tratado de Endocrinología Pediátrica y de la Adolescencia, pp 1333-1351. Eds J Argente, A Carrascosa, R Gracia & F Rodríguez. Barcelona: Doyma, 2000.
82. Leslie RD, Isaacs AJ, Gomez J, Raggat PR & Bayliss R. Hypothalamo-pituitary-thyroid function in anorexia nervosa: influence of weight gain. British Medical Journal 1978 2 526-528.
83. Stoving R, Hangaard J & Hagen C. Update on endocrine disturbances in anorexia nervosa. Journal of Pediatric Endocrinology and Metabolism 2001 14 459-480.
84. Baker D, Roberts R & Towell T. Factors predictive of bone mineral density in eating-disordered women: a longitudinal study. International Eating Disorders 2000 27 29-35.
85. Muñoz MT, Morandé G, García-Centenera JA, Hervás F & Argente J. Implications of calcium phosphate metabolism in the development of osteopenia in adolescents with anorexia nervosa. Hormone Research 1996 46 (Suppl) 327.
86. Biller BM, Saxe V, Herzog DB, Rosenthal DI, Holzman S & Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 1989 68 548-554.
87. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB & Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 1995 80 898-904.
88. Grinspoon N, Thomas E, Pitts S, Gross E, Mickley D, Miller K et al. Prevalence and predictive factors in women with anorexia nervosa. Annals of Internal Medicine 2000 133 790-794.
89. Del Río L, Carrascosa A, Pons F, Gusinyé M, Yeste D & Domenech FM. Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: change related to age, sex and puberty. Pediatric Research 1994 35 362-366.
90. Zipfel S, Lowe B, Reas DL, Deter HC & Herzog W. Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up study. Lancet 2000 355 721-722.
91. Eisman JA. Genetics of osteoporosis. Endocrine Reviews 1999 20 788-807.
92. Zipfel S, Seibel MJ, Lowe B, Beumont PJ, Kasperk C & Herzog W. Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa. Journal of Clinical Endocrinology and Metabolism 2001 86 5227-5233.
93. Backer D, Roberts R & Towell T. Factors predictive of bone mineral density in eating-disordered women women: a longitudinal study. International Journal of Eating Disorders 2000 27 29-35.
94. Karlsson MK, Weigall SJ, Duan Y & Seeman E. Bone size and volumetric density in women with anorexia nervosa receiving estrogen replacement therapy and in women recovered fron anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2000 85 3177-3182.
95. Hartman D, Crisp A, Rooney B, Rackow C, Atkinson R & Patel S. Bone density of women who have recovered from anorexia nervosa. International Journal of Eating Disorders 2000 28 107-112.
96. Muñoz MT, Morandé G, García-Centenera JA, Hervás F, Pozo J & Argente J. The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa. European Journal of Endocrinology 2002 46 45-50.
97. Miller KK & Klibanski A. Clinical review: amenorrheic bone loss. Journal of Clinical Endocrinology and Metabolism 1999 84 1775-1783.
98. Seeman E, Szmukler GI, Formica C, Tsalamandris C & Mestrovic R. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. Journal of Bone and Mineral Research 1992 7 1467-1474.
99. Ogueh O, Sooranna S, Nicolaides KH & Johnson MR. The relationship between leptin concentrations and bone metabolism in the human fetus. Journal of Clinical Endocrinology and Metabolism 2000 85 1997-1999.
100. Pasco JA, Henry MJ, Kotowicz MA, Collier GR, Ball MJ, Ugoni AM et al. Serum leptin levels are associated with bone mass in nonobese women. Journal of Clinical Endocrinology and Metabolism 2001 86 1884-1887.
101. Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M et al. Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. Journal of Clinical Endocrinology and Metabolism 2001 86 5273-5276.
102. Ducy P, Schinke T & Karsenty G. The osteohlast: a sophisticated fibroblast under central surveillance. Science 2000 289 1501-1504.
103. Ducy P, Ambling M, Takeda S, Priemel M, Schilling AF, Beil FT et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000 100 19 7-207.
104. Burguera B, Hofbauer LC, Thomas J, Gori F, Evans GL, Khosla S et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 2001 142 3546-3553.
105. Thomas T, Gori F, Khosla S, Jehsen MD, Burguera B & Riggs BL. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999 140 1630-1638.
106. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ & Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. Journal of Bone and Mineral Research 2000 15 2-12.
107. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000 289 1504-1508.
108. Taylor AE, Hubbard J & Anderson EJ. Impact of binge eating on metabolic and leptin dynamics in normal young women. Journal of Clinical Endocrinology and Metabolism 1999 84 428-434.
109. Herpertz S, Albers N, Wagner R, Pelz B, Kopp W, Mann K et al. Longitudinal changes of circadian leptin, insulin and cortisol plasma levels and their correlations during refeeding in patients with anorexia nervosa. European Journal of Endocrinology 2000 142 373-379.
110. Domínguez-Cabrera C, Sosa M, Traba ML. Álvarez E & de la Piedra C. Biochemical markers of bone formation in the study of postmenopausal osteoporosis. Osteoporosis International 1998 8 147-151.
111. Fledelius C, Johnsen AH, Cloos PAC, Bonde M & Ovist P Characterization of urinary degradation products derived from type I collagen. Journal of Biological Chemistry 1997 272 9755-9763.
112. Calero JA, Múnoz MT, Argente J, Traba ML, Méndez-Dávila C, García-Moreno C et al. A variation in bone alkaline phosphatase levels that correlates positively with bone loss and normal levels of aminoterminal propeptide of collagen I in girls with anorexia nervosa. Clinica Chimica Aeta 1999 285 121-129.
113. De la Piedra C, Calero JA, Traba ML, Asensio MD, Argente J & Muñoz MT. Urinary and C-telopeptides of collagen 1: clinical implications in bone remodeling in patients with anorexia nervosa. Osteoporosis International 1999 10 480-486.
114. Hartman D, Crisp A, Rooney B, Rackow C, Atkinson R & Patel S. Bone density of women who have recovered from anorexia nervosa. International Journal of Eating Disorders 2000 28 107-112.
115. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D & Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 1996 81 3864-3870.
116. Hotta M, Fukuda I, Sato K, Hizuka N, Shibasaki T & Takano K. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) 1, and serum IGF-binding protein levels in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2000 85 200-206.
117. Johansson AG & Rosen CJ. The IGFs as potential therapy for metabolic bone diseases. In Principles of Bone Biology, pp 1099-1109. Eds JP Bilezildan, LG Raisz & GA Rodan. San Diego: Academic Press, 1996.
118. Bianda T, Glatz Y, Bouillon R, Froesch ER & Schmid C. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 1998 83 81-87.
119. Conover CA. The role of insulin-like growth factors and binding proteins in bone cell biology. In Principles of Bone Biology, pp 607-618. Eds JP Bilezikian, LG Raisz & GA Rodan. San Diego: Academic Press, 1996.
120. Castro J, Lázaro L, Pons F, Halperín I & Toro J. Predictors of bone mineral density reduction in adolescents with anorexia nervosa. Journal of Academic Childhood Adolescent Psychiatry 2000 39 1365-1370.
121. Soyka LA, Grinspoon S, Levitsky L, Herzog D & Klibanski A. The effect of anorexia nervosa on bone metabolism in female adolescents. Journal of Clinical Endocrinology and Metabolism 1999 84 4489-4496.
122. Jagielska G, Wolanczyk T, Komender J, Tomaszewicz-Libudzic C, Przedlacki J & Ostrowaski K. Bone mineral content and bone mineral density in adolescent girls with anorexia nervosa: a longitudinal study. Acta Psychiatrica Scandinavica 2001 104 131-137.